Rodríguez-González, F Germán <br/><br/>
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  May 2011 
 - 43-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-010-0940-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--diagnosis<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>MicroRNAs--genetics<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Receptors, Estrogen--metabolism<br/>Selective Estrogen Receptor Modulators--therapeutic use<br/>Signal Transduction<br/>Survival Analysis<br/>Tamoxifen--therapeutic use